Celecoxib or diallyl trisulfide topical emulgels, alone or in combination, reduce pruritus and inflammatory cascades in a BALB/c mouse model of imiquimod-induced psoriasis
Psoriasis is a chronic, immune-mediated inflammatory skin disease for which no curative treatment currently exists, posing a significant challenge because of its deleterious effects on patients’ quality of life and its substantial economic burden on healthcare systems. Current first-line therapies, including corticoste...